FDA Has a New CIO (With Reenginering and Streamlining Experience)

Feb. 28, 2007
This just in from FDA... Timothy Stitely will become FDA's Chief Information Officer (CIO) effective March 5, 2007.  In his role as the FDA CIO, Tim will strengthen the agencys information technology infrastructure.  Tim brings a wealth of experience developing and managing innovative and cost effective multi-organizational programs in addition to extensive governmental reengineering and streamlining experience.   One of the challenges we face at FDA is modernizing and automating our information technology infrastructure to support FDA business goals.  One of Tims most recent accomplishments similar to this effort was his leadership at the Centers for Medicare and Medicaid Services (CMS) where he facilitated the design & maintenance of the Medicare Advantage & Part D systems which pay more than $10 billion monthly in benefits.  Prior to joining FDA, Tim served as the Director, Information Services Design & Development Group with the Centers for Medicare and Medicaid Services (CMS).  While at CMS, Tim led the redesign of a Legacy Fee for Service Shared Systems responsible for processing 100 million Medicare claims monthly and developed, awarded and executed the Enterprise Data Center Indefinite Delivery/Indefinite Quantity (ID/IQ) contract.  This contract provided a mechanism to transition current and new production workloads from 20+ existing data centers into two (2) enterprise data centers and continued the conversion of the CMS Data Center from Research Support into a 24 x 7 Production Data Center.  Tim is a 2004 HHS SES Candidate Development Program (CDP) graduate.  Prior to participating in the HHS SES CDP, Tim served as Senior Information Technology Advisor to the Scientific Director at the National Institute of Child Health and Human Development at NIH where he was responsible for every aspect of a complex, multi-faceted IT environment.  Tim holds a Masters of Science degree in information technology from the University of Maryland University College.
This just in from FDA... Timothy Stitely will become FDA's Chief Information Officer (CIO) effective March 5, 2007.  In his role as the FDA CIO, Tim will strengthen the agencys information technology infrastructure.  Tim brings a wealth of experience developing and managing innovative and cost effective multi-organizational programs in addition to extensive governmental reengineering and streamlining experience.   One of the challenges we face at FDA is modernizing and automating our information technology infrastructure to support FDA business goals.  One of Tims most recent accomplishments similar to this effort was his leadership at the Centers for Medicare and Medicaid Services (CMS) where he facilitated the design & maintenance of the Medicare Advantage & Part D systems which pay more than $10 billion monthly in benefits.  Prior to joining FDA, Tim served as the Director, Information Services Design & Development Group with the Centers for Medicare and Medicaid Services (CMS).  While at CMS, Tim led the redesign of a Legacy Fee for Service Shared Systems responsible for processing 100 million Medicare claims monthly and developed, awarded and executed the Enterprise Data Center Indefinite Delivery/Indefinite Quantity (ID/IQ) contract.  This contract provided a mechanism to transition current and new production workloads from 20+ existing data centers into two (2) enterprise data centers and continued the conversion of the CMS Data Center from Research Support into a 24 x 7 Production Data Center.  Tim is a 2004 HHS SES Candidate Development Program (CDP) graduate.  Prior to participating in the HHS SES CDP, Tim served as Senior Information Technology Advisor to the Scientific Director at the National Institute of Child Health and Human Development at NIH where he was responsible for every aspect of a complex, multi-faceted IT environment.  Tim holds a Masters of Science degree in information technology from the University of Maryland University College.
About the Author

pharmamanufacturing | pharmamanufacturing